| CAA | Chloroacetamide extracellular matrix |
| CIMP | Pathway characterised by the CpG island methylation phenotype |
| CIN | Chromosomal instability pathway |
| CRC | Colorectal cancer |
| CTCs | Circulating tumor cells |
| ctDNA | Circulating tumor DNA |
| ECM | Extracellular matrix |
| ESCRT | Endosomal sorting complex required for transport |
| EVs | Extracellular vesicles |
| FBS | Fetal bovine serum |
| FDR | False discovery rate |
| FISH | Fluorescence in situ hybridization |
| GO | GeneOntology, |
| IHC | Immunohistochemistry |
| ILVs | Intraluminal vesicles |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| LC | Lung cancer |
| LC–MS/MS | Liquid chromatography-tandem mass spectrometry |
| LDCT | Low-dose computed tomography |
| LFQ | Label free quantification |
| miRNA | Micro RNA |
| MSI | Microsatellite instability |
| MVEs | Multivesicular endosomes |
| NSCLC | Non-small cell lung carcinoma |
| SIS | Stable isotope-labeled peptides standards |
| SRM | Selected reaction monitoring |
| TCEP | Tris(2 carboxyethyl)phosphine |
| TEAB | Triethylammonium bicarbonate buffer |
| WhL | Whole cell lysate |